Beginning August 10, 2018, FDA will enforce a new nicotine warning Statement. Manufacturers and distributors cannot package, sell, offer to sell, distribute, or import for sale or distribution within the United States roll-your-own, cigarette tobacco, or “covered tobacco products” without the required warning label statement on the tobacco product package, per 21 CFR § 1143.3(a)(1). (Cigar required warnings are described under 21 CFR § 1143.5.)1
For the following products, including components and parts, that are sealed in final packaging intended for consumer use and are made or derived from tobacco, package labels and advertisements must bear the nicotine addictiveness warning statement:
This required warning statement must also meet certain requirements, with respect to font, text, size, placement, and formatting of the warning statement on the package labels. That is, the required warning statement on package labels must also appear directly on the package and be clearly visible underneath any cellophane or other clear wrapping, per 21 CFR § 1143.3(a)(2), as follows:
Packages that are Too Small to Display the Required Warning Statement
A “covered tobacco product” that is too small or otherwise unable to accommodate a label must
contain the required warning statement on one of the following, per 21 CFR § 1143.3(d):
There are other labeling requirements that must appear on tobacco product package labels if the product is manufactured, packaged, sold, offered for sale, distributed, or imported for sale or distribution within the United States. The following statements must appear on roll-your-own, cigarette tobacco, and “covered tobacco product” package labels per Section 903(a)(2) of the Tobacco Control Act:
Call J&J Compliance Consulting Group at 949-735-6224 to schedule a free consultation